Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Formulation

We develop inhalation & nasal products with our partners following Quality by Design principles to reach optimal product performance through robust processes.

Page
Read more

OWN it! Necessidades de Formação e Desenvolvimento FY24

Tenha um papel ativo no seu desenvolvimento pessoal. Siga o novo processo para identificar e planear as suas necessidades de formação e desenvolvimento para o ano fiscal 2024.

Page
Read more

Analytical Characterization

ËÄÉ«AV advanced characterization capabilities of inhalation and nasal products is crucial to determine their safety and efficacy.

Page
Read more